title: Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.
abstract: OBJECTIVE
  Proximal colon cancers are more likely to present with advanced stage than distal cancers; however, previous reports conflict regarding the independent prognostic significance of tumor location on survival. We examined survival by colon cancer subsite location by use of data from the California Cancer Registry.
  
  
  METHODS
  An analysis of colon cancer cases from 1994 to 2004 was conducted, with follow-up through 2006. Colon subsite location was defined as proximal colon (cecum, ascending colon, hepatic flexure), transverse colon, descending colon (splenic flexure, descending colon), and sigmoid colon. Subsite-specific survival analyses were conducted with use of the Kaplan-Meier method and Cox proportional hazards ratios.
  
  
  RESULTS
  A total of 82,926 colon cancer cases were identified, including 40,078 proximal (48%), 8,023 transverse (10%), 8,657 descending (10%), and 26,168 sigmoid cancers (32%). A larger proportion of sigmoid cancers (30.5%) presented as Stage I compared with proximal (18.5%), transverse (16.8%), or descending colon cancers (20.1%). Proximal cancers had the greater proportion with high tumor grade (27%), and had a greater mean number of lymph nodes examined. There were no differences in treatment rendered when each colon subsite was stratified by stage. After adjustment for stage, grade, treatment, lymph node examination, and other relevant clinical variables, sigmoid cancers had decreased colorectal cancer-specific mortality compared with proximal tumors (hazards ratio = 0.88; 95% confidence interval, 0.85-0.92).
  
  
  CONCLUSIONS
  In this analysis, sigmoid colon cancers were observed to have earlier stage, lower tumor grade, and independently decreased colorectal cancer-specific mortality compared with proximal tumors.
authors.affiliation: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California, USA.
authors.forename: Charlie M
authors.initials: CM
authors.lastname: Wray
authors.forename: Argyrios
authors.initials: A
authors.lastname: Ziogas
authors.forename: Marcelo W
authors.initials: MW
authors.lastname: Hinojosa
authors.forename: Hoa
authors.initials: H
authors.lastname: Le
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Stamos
authors.forename: Jason A
authors.initials: JA
authors.lastname: Zell
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002140:California / Q000453:epidemiology; D003110:Colonic Neoplasms / Q000401:mortality* / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D018426:SEER Program; D015996:Survival Rate / Q000639:trends; D055815:Young Adult